McKesson completes $2.1B acquisition of Rexall Health

San Francisco-based McKesson has wrapped up its acquisition of Mississauga, Ontario, Canada-based Rexall Health.

Advertisement

Through the $2.1 billion transaction, McKesson acquired Rexall Health’s 470 pharmacies. McKesson also agreed to sell 28 of the pharmacies as part of a consent agreement with Canada’s Competition Bureau.

“Today’s announcement marks a milestone for McKesson and Rexall Health,” said McKesson CEO John Hammergren. “With complementary assets, industry expertise and shared values, we will now serve our customers with enhanced retail pharmacy capabilities and a broader reach across Canada.”

In addition, McKesson named Domenic Pilla CEO of McKesson Canada. Effective Jan. 3, Mr. Pilla will take the helm from Jürgen Schreiber.

More articles on health IT:
FDA issues guidance on cybersecurity for medical devices
Cerner, athenahealth & more — 7 key health IT notes
CoxHealth expands telemedicine benefits across Missouri

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.